Cipla Limited has announced the successful conclusion of its recent board meeting, confirming the date for its 90th Annual General Meeting and key senior leadership appointments. The company has also approved a new round of employee stock options and appreciation rights to further incentivize its workforce. Additionally, the Board has finalized the appointment of new cost auditors for the upcoming fiscal year, marking a period of strategic organizational progress.
Strategic Leadership Appointment
As part of its organizational growth, Cipla has appointed Mr. Sushrut Kulkarni as the President & Global Chief – Integrated Product Development (IPD), effective 18th May 2026. Mr. Kulkarni brings extensive industry experience, having previously served in senior leadership roles at Dr. Reddy’s Laboratories, Glenmark, and Zydus Lifesciences. In his new capacity, he will join the company’s Management Council to spearhead research and development operations.
Annual General Meeting Scheduled
The company has officially set the date for its 90th Annual General Meeting, which is scheduled to take place on Thursday, 25th June 2026. This milestone event will bring together shareholders to review the company’s performance and address key governance matters.
Stock Incentive Programs
To align employee interests with long-term growth, the Board has approved a new grant of stock options under the ESOS 2013-A scheme and employee stock appreciation rights (ESARs) under the ESAR 2021 scheme. These grants include various tranches with vesting periods ranging from 1 to 3 years, designed to retain and motivate talent across the organization.
Appointment of Cost Auditors
For the financial year 2026-27, the company has appointed M/s Joshi Apte & Associates as Cost Auditors. The firm, which brings 16 years of expertise in cost and management accounting, will be responsible for ensuring audit compliance and professional financial oversight for the upcoming fiscal period.
Source: BSE
